筛查乳腺超声中多发双侧边界清晰肿块随访结局
该回顾性研究纳入284例筛查超声发现多发双侧边界清晰肿块(MBCM)且钼靶无异常的女性,随访中150例出现465个新发或增大的肿块。新发或增大的卵圆形、边界清晰、平行位肿块无一恶性,恶性率为0%(活检者95%CI 0-1.2%);但新发不规则肿块或原有卵圆形肿块出现可疑形态改变者中检出4例癌。
要点
- MBCM背景下新发或增大的卵圆形、边界清晰、平行位肿块恶性率为0%,可安全推迟活检。
- 需警惕新发不规则肿块或原有卵圆形肿块出现钙化、边缘不规则等形态改变。
- 年轻女性更易出现肿块增大(p < .001)。
核心结论
- MBCM背景下,新发或增大的卵圆形、边界清晰、平行位肿块为常见良性事件,恶性率为0%(活检者95%CI 0-1.2%)。
- 新发不规则肿块或原有卵圆形肿块出现可疑形态特征时应仔细评估恶性可能。
研究设计与样本
- 回顾性研究,纳入2014年1月1日至2019年7月31日间11,826例无症状女性共48,488次双侧筛查乳腺超声中284例(2.4%)符合标准的MBCM病例。
- 参考标准为活检结果或至少12个月随访;采用多变量logistic回归分析。
关键影像表现/征象
- 284例女性(平均年龄46岁,范围20-83岁)中150例(52.8%)后续出现465个新发、增大和/或改变的肿块。
- 465个肿块中408个(87.7%)为卵圆形、边界清晰、平行位且与其他MBCM相似;57个(12.3%)为非卵圆形、非边界清晰的独特表现。
- 新发或增大的卵圆形、边界清晰、平行位肿块无一恶性。
- 同时存在MBCM和独特表现者中检出4例癌:3例为新发不规则肿块,1例原有卵圆形肿块形态改变出现新钙化和不规则边缘。
诊断标准与关键数值
- MBCM女性随访中恶性率为0%(中位随访40.8个月,范围12-75个月);接受活检者恶性率为0%(95%CI 0-1.2%)。
- 年轻年龄与出现增大肿块的可能性相关(p < .001)。
临床应用与阅片要点
- MBCM背景下新发或增大的卵圆形、边界清晰、平行位肿块且无可疑形态改变时,可安全推迟活检。
- 阅片需重点识别新发不规则肿块或原有卵圆形肿块出现钙化、边缘不规则等形态改变。
局限性
- 回顾性单中心设计。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND. Breast screening ultrasound (US) has limited specificity but is increasingly performed because of widening state and federal legislation regarding breast density. There is a need for evidence-based management guidelines. OBJECTIVE. The purpose of this study was to assess outcomes of new or enlarging oval circumscribed parallel masses in the setting of multiple bilateral circumscribed masses (MBCM) at sequential rounds of US screening. METHODS. In this retrospective study of women found to have MBCM on screening breast US without mammography abnormalities, longitudinal review was performed to identify development of any new or enlarging or changing masses. Outcomes were recorded using biopsy results or minimum of 12 months of follow-up as reference standards. Lesion characteristics, BI-RADS classification, breast density, patient age, demographics, and risk factors were reviewed. Statistical analysis included multivariable logistic regression analysis. RESULTS. There were 284 (2.4%) cases of MBCM in a total of 48,488 bilateral screening US examinations performed in 11,826 asymptomatic women between January 1, 2014, and July 31, 2019, that fit inclusion criteria. Of the 284 women (mean age, 46 years; range, 20-83 years), 150 (52.8%) subsequently developed 465 new, enlarging, and/or changing masses, 107 (23.0%) of which underwent biopsy. Of the 465 masses, 408 (87.7%) were oval circumscribed parallel masses and similar to other MBCM, and 57 (12.3%) were unique findings that were nonoval noncircumscribed masses. None of the new or enlarging oval circumscribed parallel masses were malignant. In total, the malignancy rate was 0% for women with MBCM with follow-up (median, 40.8 months; range, 12-75 months) and 0% for those that underwent biopsy (95% CI, 0-1.2%). Among women with concurrent MBCM and unique findings, four cancers were detected. Three were new irregular masses, and one previously oval mass changed in morphology to have new calcifications and an irregular border. A younger age was related to the likelihood of having enlarging masses (p < .001). CONCLUSION. In the setting of MBCM, new or enlarging oval circumscribed parallel masses are a common and benign event. Concurrent new irregular masses or previously oval masses that develop suspicious morphologic features should be carefully evaluated for malignancy. CLINICAL IMPACT. Breast radiologists who encounter new or enlarging oval circumscribed parallel masses with no suspicious morphologic change in the setting of MBCM can safely defer biopsies.
引用
- Wolfson S, Heller SL, Gao Y, et al. Multiple Bilateral Circumscribed Masses at Screening Breast Ultrasound: Outcomes of New or Enlarging Masses at Follow-Up. AJR Am J Roentgenol. 2021. PMID: 34549605. doi:10.2214/AJR.21.26520
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。